Genome Biology

official impact factor 6.89

Open Access

Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes

Katleen De Preter, Jo Vandesompele, Pierre Heimann, Nurten Yigit, Siv Beckman, Alexander Schramm, Angelika Eggert, Raymond L Stallings, Yves Benoit, Marleen Renard, Anne D Paepe, Geneviève Laureys, Sven Påhlman and Frank Speleman*

Genome Biology 2006, 7:R84 doi:10.1186/gb-2006-7-9-r84

Accesses  

  • Last 30 days: 68 accesses
  • Last 365 days: 759 accesses
  • All time: 5764 accesses

Cited by

BioMed Central: 7 citations

Research   Open Access

Design of a multi-signature ensemble classifier predicting neuroblastoma patients' outcome

Andrea Cornero, Massimo Acquaviva, Paolo Fardin, Rogier Versteeg, Alexander Schramm, Alessandra Eva, Maria Bosco, Fabiola Blengio, Sara Barzaghi, Luigi Varesio BMC Bioinformatics 2012, 13(Suppl 4):S13 (28 March 2012)

Research article   Open Access

The l1-l2 regularization framework unmasks the hypoxia signature hidden in the transcriptome of a set of heterogeneous neuroblastoma cell lines

Paolo Fardin, Annalisa Barla, Sofia Mosci, Lorenzo Rosasco, Alessandro Verri, Luigi Varesio BMC Genomics 2009, 10:474 (15 October 2009)

Research article   Open Access Highly Accessed

Verification of genes differentially expressed in neuroblastoma tumours: a study of potential tumour suppressor genes

Kaisa Thorell, Annika Bergman, Helena Carén, Staffan Nilsson, Per Kogner, Tommy Martinsson, Frida Abel BMC Medical Genomics 2009, 2:53 (17 August 2009)

Review   Free

The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy

Nadine Van Roy, Katleen De Preter, Jasmien Hoebeeck, Tom Van Maerken, Filip Pattyn, Pieter Mestdagh, Joëlle Vermeulen, Jo Vandesompele, Frank Speleman Genome Med 2009, 1:74 (27 July 2009)

Genomic, epigenetic and microRNA changes influence the development and severity of neuroblastoma, and copy number variations can now be used to form genomic subgroups which correlate with clinical outcome.

Research article   Open Access

CADM1 is a strong neuroblastoma candidate gene that maps within a 3.72 Mb critical region of loss on 11q23

Evi Michels, Jasmien Hoebeeck, Katleen De Preter, Alexander Schramm, Bénédicte Brichard, Anne De Paepe, Angelika Eggert, Geneviève Laureys, Jo Vandesompele, Frank Speleman BMC Cancer 2008, 8:173 (17 June 2008)

BAC array analysis of chromosome 11 status on both primary tumors and cell ines and meta-analysis of expression profiles of 692 neuroblastoma samples suggest that CADM1 is a potential neuroblastoma suppressor gene.

Research   Open Access

Involvement of GTA protein NC2β in Neuroblastoma pathogenesis suggests that it physiologically participates in the regulation of cell proliferation

Cinzia Di Pietro, Marco Ragusa, Davide Barbagallo, Laura R Duro, Maria R Guglielmino, Alessandra Majorana, Veronica Giunta, Antonella Rapisarda, Elisa Tricarichi, Marco Miceli, Rosario Angelica, Agata Grillo, Barbara Banelli, Isabella Defferari, Stefano Forte, Alessandro Laganà, Camillo Bosco, Rosalba Giugno, Alfredo Pulvirenti, Alfredo Ferro, Karl H Grzeschik, Andrea Di Cataldo, Gian P Tonini, Massimo Romani, Michele Purrello Molecular Cancer 2008, 7:52 (6 June 2008)

Correction   Free

Correction: Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes

Katleen De Preter, Jo Vandesompele, Pierre Heimann, Nurten Yigit, Siv Beckman, Alexander Schramm, Angelika Eggert, Raymond L Stallings, Yves Benoit, Marleen Renard, Anne De Paepe, Geneviève Laureys, Sven Påhlman, Frank Speleman Genome Biology 2007, 8:401 (31 January 2007)